{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:43:03Z","timestamp":1758588183481,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.7759\/cureus.92960","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:44:33Z","timestamp":1758577473000},"source":"Crossref","is-referenced-by-count":0,"title":["Multicancer Early Detection Test Usage at Different National Comprehensive Cancer Network and National Cancer Institute-Designated Cancer Centers"],"prefix":"10.7759","author":[{"given":"Maria","family":"Powers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Kitchens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrithika","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarinthia E","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"American Cancer Society. Multi-cancer early detection (MCED) tests. (2024). Accessed. April 10, 2025: https:\/\/www.cancer.org\/cancer\/screening\/multi-cancer-early-detection-tests.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00568-z","article-title":"A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening","volume":"8","author":"Vittone J","year":"2024","unstructured":"Vittone J, Gill D, Goldsmith A, Klein EA, Karlitz JJ. A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening. NPJ Precis Oncol. 2024, 8:91. 10.1038\/s41698-024-00568-z","journal-title":"NPJ Precis Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02230-y","article-title":"Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients","volume":"20","author":"Merriel SWD","year":"2022","unstructured":"Merriel SWD, Pocock L, Gilbert E, Creavin S, Walter FM, Spencer A, Hamilton W. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022, 20:54. 10.1186\/s12916-021-02230-y","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin D","year":"2021","unstructured":"Lin D, Shen L, Luo M, et al.. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021, 6:404. 10.1038\/s41392-021-00817-8","journal-title":"Signal Transduct Target Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060935","article-title":"Shifting the cancer screening paradigm: the rising potential of blood-based multi-cancer early detection tests","volume":"12","author":"Brito-Rocha T","year":"2023","unstructured":"Brito-Rocha T, Const\u00e2ncio V, Henrique R, Jer\u00f3nimo C. Shifting the cancer screening paradigm: the rising potential of blood-based multi-cancer early detection tests. Cells. 2023, 12:935-54. 10.3390\/cells12060935","journal-title":"Cells"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.10.022","article-title":"Evaluation of cell-free DNA approaches for multi-cancer early detection","volume":"40","author":"Jamshidi A","year":"2022","unstructured":"Jamshidi A, Liu MC, Klein EA, et al.. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell. 2022, 40:1537-49. 10.1016\/j.ccell.2022.10.022","journal-title":"Cancer Cell"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.08.010","article-title":"Circulating cell-free DNA-based multi-cancer early detection","volume":"10","author":"Zhang K","year":"2024","unstructured":"Zhang K, Fu R, Liu R, Su Z. Circulating cell-free DNA-based multi-cancer early detection. Trends Cancer. 2024, 10:161-74. 10.1016\/j.trecan.2023.08.010","journal-title":"Trends Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051244","article-title":"Multi cancer early detection by using circulating tumor DNA-the Galleri test. Reply to Klein et al. The promise of multicancer early detection. Comment on \"Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171\"","volume":"12","author":"Pons-Belda OD","year":"2022","unstructured":"Pons-Belda OD, Fernandez-Uriarte A, Diamandis EP. Multi cancer early detection by using circulating tumor DNA-the Galleri test. Reply to Klein et al. The promise of multicancer early detection. Comment on \"Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11, 2171\". Diagnostics (Basel). 2022, 12:1244. 10.3390\/diagnostics12051244","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen JD","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, et al.. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018, 359:926-30. 10.1126\/science.aar3247","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.21","article-title":"Diagnosis: CancerSEEK and destroy\u2014a blood test for early cancer detection","volume":"15","author":"Killock D","year":"2018","unstructured":"Killock D. Diagnosis: CancerSEEK and destroy\u2014a blood test for early cancer detection. Nat Rev Clin Oncol. 2018, 15:133. 10.1038\/nrclinonc.2018.21","journal-title":"Nat Rev Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen X","year":"2021","unstructured":"Chen X, Gole J, Gore A, et al.. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat Commun. 2021, 11:3475. 10.1038\/s41467-020-17316-z","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2023.2173773","article-title":"Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim report from a Vietnamese longitudinal prospective cohort study of 2795 participants","volume":"41","author":"Nguyen THH","year":"2023","unstructured":"Nguyen THH, Lu YT, Le VH , et al.. Clinical validation of a ctDNA-based assay for multi-cancer detection: an interim report from a Vietnamese longitudinal prospective cohort study of 2795 participants. Cancer Invest. 2023, 41:232-48. 10.1080\/07357907.2023.2173773","journal-title":"Cancer Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/GO.2023.9.Supplement_1.156","article-title":"Integrating multi-omics features for blood-based multi-cancer early detection","volume":"9","author":"Mao M","year":"2023","unstructured":"Mao M, Li X, Zhang Y, et al.. Integrating multi-omics features for blood-based multi-cancer early detection. JCO Glob Oncol. 2023, 9:156. 10.1200\/GO.2023.9.Supplement_1.156","journal-title":"JCO Glob Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21817","article-title":"MCED blood test boosts cancer detection in symptomatic patients","volume":"73","author":"Fillon M","year":"2023","unstructured":"Fillon M. MCED blood test boosts cancer detection in symptomatic patients. CA Cancer J Clin. 2023, 73:552-4. 10.3322\/caac.21817","journal-title":"CA Cancer J Clin"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang M","year":"2021","unstructured":"Zhang M, Cheng S, Jin Y, Zhao Y, Wang Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021, 1875:188503. 10.1016\/j.bbcan.2021.188503","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2021.09.012","article-title":"Multi-cancer screening tests: communicating about risks should be prioritized","volume":"135","author":"Olivier T","year":"2022","unstructured":"Olivier T, Gill J, Prasad V. Multi-cancer screening tests: communicating about risks should be prioritized. Am J Med. 2022, 135:413-5. 10.1016\/j.amjmed.2021.09.012","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxae039","article-title":"Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside","volume":"2","author":"Miller SJ","year":"2024","unstructured":"Miller SJ, Sly JR, Rolfo C, et al.. Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside. Health Aff Sch. 2024, 2:qxae039. 10.1093\/haschl\/qxae039","journal-title":"Health Aff Sch"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2015.151","article-title":"Health literacy impact on national healthcare utilization and expenditure","volume":"4","author":"Rasu RS","year":"2015","unstructured":"Rasu RS, Bawa WA, Suminski R, Snella K, Warady B. Health literacy impact on national healthcare utilization and expenditure. Int J Health Policy Manag. 2015, 4:747-55. 10.15171\/ijhpm.2015.151","journal-title":"Int J Health Policy Manag"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.NURSE.0000547717.61986.25","article-title":"Confronting barriers to improve healthcare literacy and cultural competency in disparate populations","volume":"48","author":"Polster DS","year":"2018","unstructured":"Polster DS. Confronting barriers to improve healthcare literacy and cultural competency in disparate populations. Nursing. 2018, 48:28-33. 10.1097\/01.NURSE.0000547717.61986.25","journal-title":"Nursing"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399535-multicancer-early-detection-test-usage-at-different-national-comprehensive-cancer-network-and-national-cancer-institute-designated-cancer-centers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:44:35Z","timestamp":1758577475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399535-multicancer-early-detection-test-usage-at-different-national-comprehensive-cancer-network-and-national-cancer-institute-designated-cancer-centers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.92960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}